Skip to content

St. John's Wort Photodynamic Therapy

A Randomized Split-face Study of Photodynamic Therapy With St. John's Wort Versus Indole-3-acetic Acid for the Treatment of Acne

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05073211
Acronym
SJWPDT
Enrollment
31
Registered
2021-10-11
Start date
2020-06-01
Completion date
2021-09-01
Last updated
2021-10-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acne

Brief summary

The investigators aimed to evaluated the efficacy and safety of SJW-PDT compared to indole-3-acetic acid (IAA)-PDT in the treatment of acne. The investigators also investigated the skin rejuvenating effects of SJW-PDT.

Interventions

PROCEDUREPDT

A 630 nm red light and a 520 nm green light of the light-emitting diode (LED) device (Nouvo-GB®) with an intensity of 35 mW⁄cm2 was simultaneously illuminated for 10 minutes (a total light dose of 21 J/cm2). Participants received a total of four treatments at 1-week intervals and were followed up 1 and 4 weeks after the last treatment.

Sponsors

Seoul National University Bundang Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Intervention model description

a double-blind split-face randomized controlled design

Eligibility

Sex/Gender
ALL
Age
25 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* patients with mild to moderate facial acne * between 25 and 60 years old

Exclusion criteria

* history of oral retinoid treatment with the past 6 months * history of oral antibiotics, topical acne treatment, or skin rejuvenation treatment such as lasers and chemical peeling within the month before the start of the study

Design outcomes

Primary

MeasureTime frameDescription
acne lesions1 and 4 weeks after the last treatmentchange in the number of acne lesions after the treatment

Secondary

MeasureTime frameDescription
sebum secretion rate (μg/cm2)1 and 4 weeks after the last treatmentSebum secretion rate was measured with Sebumeter SM 815®.

Other

MeasureTime frameDescription
erythema index (arbitrary unit)1 and 4 weeks after the last treatmentThe erythema index (EI) was measured with Mexameter MX 1® (Courage & Khazaka)
skin texture, wrinkles (arbitrary unit)1 and 4 weeks after the last treatmentThe skin texture and wrinkles were measured with an Antera 3D® camera (Miravex Limited, Dublin, Ireland).

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026